logo     small logo upcfbih    

Faruk Skenderi, MD, MSc

Faruk Skenderi

Pathologist

Affiliation

Department of Pathology and Cytology
University of Sarajevo Clinical Center
Address: Bolnička 25, 71000 Sarajevo, Bosnia and Herzegovina
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Degrees and Training

  • Pathologist (2017)
  • Pathology Resident, University of Sarajevo Clinical Center (2012 - 2017)
  • PhD student, University of Zagreb School of Medicine, Croatia (2013 - )
  • MSc, University of Sarajevo, Bosnia and Herzegovina and University of Rijeka, Croatia (2009 - 2011)
  • Research training, Center for Proteomics, University of Rijeka, Croatia (2009 - 2010)
  • MD, University of Sarajevo Faculty of Medicine, Bosnia and Herzegovina (2006)

 Experience, positions, appointments

  • Associate Editor, BMC Cancer Cell International (2019 - )
  • Lecturer, University of Sarajevo Medical Faculty (2017 - )
  • Managing Editor, Bosnian Journal of Basic Medical Sciences (2014 - )
  • Secretary, Association of pathologists and cytologists of FBIH (2014 - )
  • Teaching and research assistant in Pathology, Univesity of Sarajevo Faculty of Health Sciences (2015 - )
  • Teaching and research assistant in Biochemistry, University of Sarajevo Medical Faculty (2008 - 2012)
  • Organizer, Bryan Warren School of Pathology (2012 - )
  • Organizer, Bosnian Turkish School of Cytopathology (2016 - )

Memberships

  • European Society of Pathology
  • International Society for Urological Pathology (ISUP)

Fellowships and Awards

  • Marie Curie Actions, Early stage research fellow (2009 - 2010)
  • Erasmus Mundus Basileus fellowship (2009)
  • Dean's award for excellence (2006)

Peer reviewer

Publications

  1. Dzinic SH, Mahdi Z, Bernardo MM, Vranic S, Beydoun H, Nahra N, Alijagic A, Harajli D, Pang A, Saliganan DM, Rahman AM, Skenderi F, Hasanbegovic B, Dyson G, Beydoun R, Sheng S. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma. PLoS One. 2019 Apr 19;14(4):e0215089. doi: 10.1371/journal.pone.0215089. eCollection 2019.
  2. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. Letter to the Editor/Response. Breast J. 2019 May;25(3):569. doi: 10.1111/tbj.13284. Epub 2019 Apr 13.
  3. Alaghehbandan R, Ulamec M, Martinek P, Pivovarcikova K, Michalova K, Skenderi F, Hora M, Michal M, Hes O. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases. Ann Diagn Pathol 2019;38:80-86
  4. Terlević R, Perić Balja M, Tomas D, Krušlin B, Vranic S, Skenderi F. Demirović A. Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer. Ann Diagn Pathol 2019;38:62-6..
  5. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. A Clinicopathologic Study of Invasive Apocrine Carcinoma of the Breast: A single center experience. Breast J. 2018 Nov;24(6):1105-1108. doi: 10.1111/tbj.13140. Epub 2018 Sep 21.
  6. Kardum V, Karin V, Glibo M, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas. Ann Diagn Pathol. 2017 Dec;31:45-49. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2017.07.002
  7. Petersson F, Martinek P, Vanecek T, Pivovarcikova K, Peckova K, Ondic O, Perez-Montiel D, Skenderi F, Ulamec M, Nenutil R, Hora M, Svoboda T, Rotterova P, Dusek M, Michal M, Hes O. Renal Cell Carcinoma With Leiomyomatous Stroma: A Group of Tumors With Indistinguishable Histopathologic Features, But 2 Distinct Genetic Profiles: Next-Generation Sequencing Analysis of 6 Cases Negative for Aberrations Related to the VHL gene. Appl Immunohistochem Mol Morphol. 2017 Oct 27. doi: 10.1097/PAI.0000000000000410. [Epub ahead of print].
  8. Skenderi F, Ulamec M, Vanecek T, Martinek P, Alaghehbandan R, Pane Foix M, Babankova I, Perez Montiel D, Alavarado-Cabrero I, Svajdler M, Dubinsky P, Cempirkova D, Pavlovsky M, Vranic S, Daum O, Ondic O, Pivovarcikova K, Michalova K, Hora M, Rotterova P, Stehlikova A, Michal M, Dusek M, Hes O. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases. Ann Diagn Pathol 2017;27:48-56. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2017.01.005
  9. Michal M, Kazakov D, Agaimy A, Hosova M, Michalova K, Grossmann P, Steiner P, Skenderi F, Vranic S, Michal M. Whorling Cellular Perineurioma: A previously undescribed variant closely mimicking monophasic fibrous synovial sarcoma. Ann Diagn Pathol 2017;27:74-8. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2017.02.001
  10. Peckova K, Martinek P, Pivovarcikova K, Vanecek T, Alaghehbandan R, Prochazkova K, Perez Montiel D, Hora M, Skenderi F, Ulamec M, Rotterova P, Daum O, Ferda J, Davidson W, Ondic O, Dubova M, Michal M, Hes O. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases. Ann Diagn Pathol. 2017 Feb;26:23-30. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2016.10.007
  11. Foix MP, Dunatov A, Martinek P, Mundó EC, Suster S, Sperga M, Lopez JI, Ulamec M, Bulimbasic S, Montiel DP, Alaghehbandan R, Peckova K, Pivovarcikova K, Ondrej D, Rotterova P, Skenderi F, Prochazkova K, Dusek M, Hora M, Michal M, Hes O. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant. Virchows Arch. 2016 Dec;469(6):669-678. http://dx.doi.org/10.1007/s00428-016-2022-x
  12. Skenderi F, Chikha A, Ibisevic N, Tatarevic-Suko A, Kantardzic N, Vranic S. Skeletal Muscle Metastases from Squamous Cell Carcinoma of the Cervix: Report of Two Cases With Literature Review. Int J Gynecol Pathol. 2017 Jan;36(1):95-100. DOI: http://dx.doi.org/10.1097/PGP.0000000000000298
  13. Fabijanovic D, Zunic I, Nikuseva Martic T, Skenderi F, Serman L, Vranic S. The expression of SFRP1, SFRP3, DVL1 and DVL2 proteins in germ cell tumors of the testis. APMIS. 2016 Nov;124(11):942-949. DOI: http://dx.doi.org/10.1111/apm.12588
  14. Damjanov I, Skenderi F, Vranic S. Mammary Analogue Secretory Carcinoma (MASC) of the salivary gland: A new tumor entity. Bosn J Basic Med Sci. 2016 Aug 2;16(3):237-8. DOI: http://dx.doi.org/10.17305/bjbms.2016.1321
  15. Ulamec M, Skenderi F, Trpkov K, Kruslin B, Vranic S, Bulimbasic S, Trivunic S, Perez Montiel D, Peckova K, Pivovarcikova K, Ondic O, Daum O, Rotterova P, Hora M, Michal M, Hes O. Solid papillary renal cell carcinoma: Clinicopathologic, morphologic and immunohistochemical analysis of 10 cases and review of the literature. Ann Diagn Pathol. 2016 Aug;23:51-7. DOI: http://dx.doi.org/10.1016/j.anndiagpath.2016.04.008
  16. Pivovarcikova K, Peckova K, Martinek P, Montiel DP, Kalusova K, Pitra T, Hora M, Skenderi F, Ulamec M, Daum O, Rotterova P, Ondic O, Dubova M, Curik R, Dunatov A, Svoboda T, Michal M, Hes O. "Mucin"-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases. Virchows Arch. 2016 Jul;469(1):71-80. DOI: http://dx.doi.org/10.1007/s00428-016-1936-7
  17. Redzepagic J, Skenderi F, Bajrovic J, Beslagic V, Ibisevic N, Vranic S. Low-grade malignant peripheral nerve sheath tumor of the breast: A report of the first case and literature review. APMIS 2016; 124:428-430. DOI: http://dx.doi.org/10.1111/apm.12515.
  18. Ulamec M, Skenderi F, Zhou M, Krušlin B, Martínek P, Grossmann P, et al. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases. Appl Immunohistochem Mol Morphol. 2016 Aug;24(7):521-30. DOI: http://dx.doi.org/10.1097/PAI.0000000000000213
  19. Damjanov I, Vranic S, Skenderi F. Does everything a surgeon takes out have to be seen by a pathologist? A review of the current pathology practice. Virchows Archiv. 2016;468(1):69-74. http://dx.doi.org/10.1007/s00428-015-1801-0
  20. Skenderi F, Vranic S, Damjanov I. Regulated cell death in diagnostic histopathology. Int J Dev Biol. 2015;59(1-3):149-58. doi: http://dx.doi.org/10.1387/ijdb.150037fs.
  21. Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova N, Rotterova P, et al. Cystic renal oncocytoma and tubulocystic renal cell carcinoma. Morphological and immunohistochemical study. Appl Immunohistochem Mol Morphol. 24(2):112-9. doi: http://dx.doi.org/10.1097/PAI.0000000000000156.
  22. Skenderi F, Krakonja F, Vranic S. Infarcted fibroadenoma of the breast: Report of two cases with review of the literature. Diagn Pathol 2013;8(1):38. DOI: http://dx.doi.org/10.1186/1746-1596-8-38
  23. Udovicic-Gagula D, Skenderi F, Gornjakovic S, Ibisevic N, Chikha A, Vranic S, Đuran A. Uterine cervix squamous cell carcinoma metastatic to the Ampulla of Vater: a case report with review of the literature. Journal of Health Sciences. 2013;3(2):173-176. DOI: http://dx.doi.org/10.17532/jhsci.2013.84
  24. Skenderi F, Jonjic S. Viral vaccines and vectors–some lessons from cytomegaloviruses. Periodicum biologorum. 2012;114(2):201-210 [PDF]
  25. Mehic B, Valjevac A, Skenderi F. First decade of publishing of Bosnian Journal of Basic Medical Sciences. Bosn J Basic Med Sci. 2011;11(4):201-204. PMC: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362571/
  26. Kiseljakovic E, Jadric R, Hasic S, Skenderi F, Resic H, Winterhalter-Jadric M. Polymorphism in methylentetra-hydrofolate reductase gene: important role in diseases. Bosn J Basic Med Sci. 2008;8(2):165-169. https://dx.doi.org/10.17305/bjbms.2008.2975

Conference papers

  1. Gatalica S, Vranic S, Stafford P, Skenderi F, Swensen J, Xiu J, Spetzler D. Spindle cell carcinoma of the breast: rare cancer with potentially targetable biomarkers. Ann Oncol 2019;30(suppl.3):mdz095.057, https://doi.org/10.1093/annonc/mdz095.057
  2. Predatory Journals in Oncology: A Critical Appraisal. Ibrahim Abdelhafez, Yaman M. Alahmad, Faruk Skenderi, Semir Vranic. 2nd World Congress on Undergraduate Research, Oldenburg, Germany, 2018
  3. V Karin, A Skrtic, F Skenderi, N Ibisevic, S Vranic, L Serman. DNA promoter methylation status and protein expression of SHh and IHh in serous ovarian carcinomas. Annals of Oncology, 2018;29(3).https://doi.org/10.1093/annonc/mdy047.016
  4. Semir Beslija, Anes Pasic, Elma Kapisazovic, Berisa Hasanbegovic, Emir Sokolovic, Faruk Skenderi, Timur Ceric. Neoadjuvant trastuzumab + pertuzumab in HER2 positive breast cancer in a country with limited resources: Evaluation of complete pathological response in a real world practice. Journal of Clinical Oncology 2018 36:15_suppl, e12661-e12661.
  5. Karin V, Skrtic A, Skenderi F, Ibisevic N, Vranic S, Serman L. The status of SHH and IHH in serous ovarian carcinomas. Ann Oncol 2018;31(suppl_3):mdy047.016. (TAT 2018 – Targeted Anticancer Therapies, Paris, March 2018).
  6. Karin-Kujundzic V, Kardum V, Skrtic A, Skenderi F, Vranic S, Serman L. Expression of Dishevelled family proteins DVL1, DVL2 and DVL3 in serous ovarian carcinomas. Proceedings of the 2nd Frankfurt Conference on Quality Control in Life Processes & 8th International p63/p73 Workshop, September 2-6, 2018, Proceedings, pp 112-3 (Poster P1-031)
  7. Ibisevic N, Chikha A, Humackic A, Guzin Z, Bilalovic N, Vranic S, Skenderi F.  Diagnostic performance and concordance of histological and radiological findings on breast core needle biopsy: three years’ experience. (XXXII Congress of International Academy of Pathology, Amman, 2018)
  8. Masic S, Bacalja J, Vucic M, Cupic H, Tomas D, Ulamec M, Spajic B, Skenderi F, Kruslin B. Correlation of expression of Tgf-ß, Mmp2 and Lmo2 between prostatic adenocarcinoma and adjacent unaffected parenchyma. Virchows Arch 2018, suppl., in press. (30th European Congress of Pathology, Bilbao 2018)
  9. Ulamec M, Bacalja J, Masic S, Dzombeta T, Stimac G, Tomaskovic I, Skenderi F, Kruslin B. Clefting and the expression of E-cadherin and Lmo2 in prostatic adenocarcinoma. Virchows Arch 2018, suppl., in press. (30th European Congress of Pathology, Bilbao 2018)
  10. Terlevic R, Perić Balja M, Tomas D, Kruslin B, Vranic S, Skenderi F, Demirovic A. Somatostatin receptor expression in neuroendocrine breast cancer. Virchows Arch 2018, suppl., in press. (30th European Congress of Pathology, Bilbao 2018)
  11. Semir Beslija, Anes Pasic, Elma Kapisazovic, Berisa Hasanbegovic, Emir Sokolovic, Faruk Skenderi, Timur Ceric. Neoadjuvant trastuzumab + pertuzumab in HER2 positive breast cancer in a country with limited resources: Evaluation of complete pathological response in a real world practice. Journal of Clinical Oncology 2018;36(15suppl):e12661
  12. Aida Catic, Amina Kurtovic-Kozaric, Ardis Sophian, Lech Mazur, Faruk Skenderi, Ondrej Hes, Stephen Rohan, Dinesh Rakheja, Jillene Kogan, Michael R Pins. Prevalence of KANK1-NTRK3 fusion in renal metanephric adenomas that lack BRAF mutations. Cancer Genetics 2018; 224:59
  13. AlAhmad YFM, Abdelhafez IHE, Cyprian FS, Skenderi F, Akhtar S, Vranic S. Predatory journals in pathology: A comprehensive assessment. IAP 2018 (Amman, Jordan)
  14. Karin V, Skrtic A, Skenderi F, Ibisevic N, Vranic S, Serman L. The status of SHH and IHH in serous ovarian carcinomas. Ann Oncol 2018;31(suppl_3):mdy047.016. (TAT 2018 – Targeted Anticancer Therapies, Paris, March 2018).
  15. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. Clinicopathologic characteristics of invasive apocrine carcinoma of the breast: A single center experience from a country with limited resources. Eur J Cancer 2018, suppl., in press (EBCC-11, Barcelona 2018).
  16. Karin V, Kakarigi L, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Sonic Hedgehog proteins are overexpressed in high-grade serous ovarian carcinomas. Libri Oncologici 2016;44(1):38.
  17. Karin V, Kardum V, Glibo M, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas. 10th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine. Dubrovnik, June 19-24, 2017.
  18. Demirović A, Vranić S, Skenderi F, Perić Balja M, Ulamec M, Vučić M, Krušlin B. Primary neuroendocrine carcinoma of the breast: a diagnostic approach to the rare primary breast malignancy. J Neuroendocrinol 2017, suppl., in press. (14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. 8-10 March 2017, Barcelona, Spain).
  19. Michal M, Kazakov DV, Agaimy A, Michalova K, Grossmann P, Skenderi F, Vranic S, Michal M. Whorling Cellular Perineurioma: An undescribed benign tumor mimicking monophasic fibrous synovial sarcoma. Mod Pathol 2017;30(supplement 2s):20A.
  20. Mahdi Z, Dzinic SH, Vranic S, Skenderi F, Sheng S, Beydoun R. Differential Expression and Subcellular Localization of Tumor Suppressor Maspin as a Diagnostic Marker in Gastroesophageal Junction Carcinoma and Its Precursors. Mod Pathol 2017;30(supplement 2s):185A.
  21. Karin V, Kakarigi L, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Sonic Hedgehog proteins are overexpressed in high-grade serous ovarian carcinomas. Fourth Meeting of the Croatian Association for Cancer Research, November 3-4, 2016.
  22. Fabijanovic D, Zunic I, Nikuseva Martic T, Skenderi F, Serman L, Vranic S. The members of Wnt pathway SFRP1, SFRP3 and DVL1 are downregulated in testicular germ cell tumors. Virchows Arch 2016;469(suppl.1):S218-9.
  23. Skenderi F, Ibisevic N, Topcagic J, Bilalovic N, Vranic S. Breast cancer incidence, demographic, and pathological characteristics in Bosnia and Herzegovina. Virchows Arch 2016;469(suppl.1):S58.
  24. Skenderi F, Ulamec M, Vranic S, Michal M, Hes O. Warthin-like papillary renal cell carcinoma with prominent lymphocytic infiltrate: Morphologic and immunohistochemical study. Virchows Arch 2016;469(suppl.1):S14.
  25. Ibisevic N, Skenderi F, Chikha A, Bilalovic N, Vranic S. Cervical cancer incidence, demographic and pathologic characteristics in Bosnia and Herzegovina. Virchows Arch 2016;469(suppl.1):S289.
  26. Chikha A, Ibisevic N, Skenderi F, Bilalovic N, Kulovac B, Selimović M, Vranic S. Spermatocytic seminoma: Report of three cases. Virchows Arch 2016; 469(suppl.1):S236.
  27. Cesarec S, Kirgin MS, Skenderi F, Ulamec M, Stimac G, Chikha A, Vranic S, Kruslin B. Sarcomatoid variant of urothelial carcinoma of the urinary bladder. A study of 27 cases. Virchows Arch 2015;467(suppl.1):S263.
  28. Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova K, Rotterova P, Kokoskova B, Branzovsky J, Michal M, Hes O. Cystic renal oncocytoma and tubulocystic renal cell carcinoma: Morphological and immunohistohemical study. Pathology 2014;46(S2):135-6.
  29. Chikha A, Jukovic Bihorac F, Skenderi F, Krakonja F, Bilalovic N, Vranić S. Infarcted fibroadenoma of the breast: report of two cases. Histopathology. 

Books/Chapters

  1. Ivan Damjanov, Semir Vranic, Faruk Skenderi. Review of Gynecologic and Breast Pathology. Jaypee Brother Medical Publishers (P) Ltd. 2017. URL: Amazon, Book Depository, Wisepress

Updated 13 June 2019

Newsletter

Sign up for news from our website (announcements, availability of program and course materials; 2-5 emails per year).